Latar belakang: Penelitian in vitro ekstrak kulit buah manggis (Garcinia mangostana L.) (EKBM) 
Acne vulgaris (AV) is a dermatologic major problem especially in adolescence, since this disease is mainly manifest on the face and concerns with esthetical appearance. AV may manifest as transient dermatologic lesion which elapse within several days, but in some patients it becomes chronic. The average prevalence of AV is 75-85% in adults. 1 At the age of 20 to 30 years, the prevalence of AV in women is 50.9% and 42.5% in men, 2 and then decreases with age.
3 Etiopathology of AV is multifactorial. Infection of Propionibacterium acnes is considered as the main etiology of AV, but the roles of oxidative stress and hormonal influences seem to be important.
AV is characterized by excessive sebum production, 4 follicular hyperkeratinisation, and increased release of inflammatory chemical substances. Oxidative stress presumably plays an important role in the pathogenesis of AV, because oxidative stress alters the condition of the pilosebaceous unit which originally is not suitable for the growth of anaerobic bacteria, especially Propionibacterium acnes. 5 Exposure of pilosebaceous keratinocyte cells to surface protein of Propionibacterium acnes induces formation of free radicals superoxide O 2 leading to lipid peroxidation of sebum. Neutrophils kill propionibacterium by producing hydrogen peroxide (H 2 O 2 ) resulted in inflammation and further tissue damage. 6 Polyunsaturated fatty acid, the component of membrane cells damaged by oxidative stress, will form malondialdehyde (MDA) which has been recognized as an important lipid peroxidation indicator. 7 This can be used as a marker for diagnosis and follow up the progress of AV. The level of MDA in AV patient has been shown higher than healthy person. 8 Endogenous and exogenous antioxidants may play a role in scavenging free radicals influencing the severity of AV. Extensive laboratory research has suggested a strong link between the mechanisms by which oxidative stress leads to chronic inflammation, which in turn may mediate a wide array of chronic diseases including acne vulgaris. 9 Garcinia mangostana L (mangosteen) is a natural raw materials of exogenous sources of antioxidants has been investigated in vitro. Amongst colorful fruits rich in anthocyanins (phenolic compounds), mangosteen rind is known to contain the family of bioactive xanthones that can inhibit the activities of unpaired electrons in free radicals by donating H (hydrogen) atoms. 10 In vitro study showed that xanthone compounds, α-mangostin, promote strong antimicrobial activity against Propionibacterium acnes 11 and other study showed its anti-inflammatory effect.
12
This study was aimed to evaluate the efficacy of mangosteen rind extract given orally in term of clinical effectiveness as well as its influence on oxidative stress parameter.
METHODS

Subjects
This was a randomized, phase-3, placebo controlled clinical trial on subjects with mild to moderate acne vulgaris, conducted between July-September 2012. Subjects were students of Nurse Academy in Jakarta (18-30 years old), living in the dorm and suffering from mild to moderate AV, not pregnant and no allergic history to the extract. Written informed consent was obtained from each volunteer participating in this study. The sample size was calculated based on the formula of two independent proportion, and 42 subjects in each group was needed. With additional anticipated 10% drop out, 94 subjects were finally recruited.
Study drug
The subjects were randomly alocated to receive either extract of mangosteen rind (EMR) containing 400 mg extracts of mangosteen rind or placebo capsules with the same appearance. EMR capsules are produced by PT Sido Muncul and marketed under BPOM (Indonesian National Agency on Food and Drug Administration and Control) registration number of TR. 112 325 671.
The capsules were given three times daily for 3 weeks. Numbers of AV lesions is calculated at the beginning and at the end of the study and classified as inflamed (papules, pustules) and non-inflamed lesion (comedos). Photography in the face, upper chest and back were obtained by permission from the subjects.
Standard therapy
As an ethical reason, topical cream containing retinoic acid 0.025% have been given to all subjects (in control and treatment group) to be applied on AV lesions in the face only, during night time. Before (in the evening before sleep) and after (in the morning) applying topical cream, all subject should wash his/her face with soft soap which was also provided.
Blood specimens
For evaluating the levels of MDA we randomized 20 subjects in each group, calculated based on previous study by Surlinia. 8 After randomization of the subjects, 2 subjects in control group were dropped out, hence there were 18 subjects in control group and 20 subjects in treatment group whose blood specimen were taken.
Blood specimen was taken from fore arm vein and kept with heparin anti-coagulant in refrigerator at -20 o C until analysis. Level of plasma MDA was measured by TBARS assay. 13 The analysis is done at the laboratory of Department of Biochemistry and Oxidative Stress Centre, Faculty of Medicine, Universitas Indonesia.
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Study parameters and data analysis
Acne severity
Number of AV lesions in photos of the face, upper chest and back were calculated, classified as inflamed (papules & pustules) and non-inflamed (comedos) lesions. To evaluate the efficacy of the treatment, we define the success as 20% reduction in numbers of AV lesion. The changes in acne severity (mild, moderate or severe AV) were assessed according to Lehman's criteria with a scoring system to measure the severity of AV 14 in accordance with photographic technique scores.
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The change of numbers of AV lesions before and after treatment within the same group was analyzed by paired t-test and the comparison between group at the end of study was performed with unpaired t-test. In accordance with predilection of acne, the number of lesions was divided into 3 different areas that are face, upper chest and back. The proportions of subjects, who met the success rate definition in each group, were analyzed by chi-square test.
Plasma MDA level
The results of MDA level in each group, before and after treatment, were analyzed by paired-t-test. The results of MDA level, after treatment, were analyzed by unpaired-t-test. A p-value of < 0.05 was taken as the limit of statistical significance.
RESULTS
Demography of the subjects
The demographic characteristics of the subjects are shown in Table 1 . It is seen that subjects' characteristics are equally distributed in both groups.
Parameter
Control group (n = 41) 
AV severity assessed by number of acne lesions
The numbers of AV lesions before and after treatment are showed in Table 2 . Overall, reduction of total lesion was higher in treated compared to control group, 37 vs 27% (p < 0.05). The reduction of non-inflamed lesions (comedos) was higher (63%) than inflamed (papules + pustules) lesions (35%) after three weeks treatment with mangosteen extracts (p < 0.05). Whereas in control group, the reduction of numbers of lesions was higher in inflamed lesions (32%) than non-inflamed (23%).
AV severity remission
The proportion of subjects who met the criteria of success tend to be higher in treatment group compared to control group. This occured for total lesion, as well as separately on the face, back, and neck. The difference was more discrete in non-inflamed lesions (comedo). However, statistical analysis did not show any significant difference ( Figure 1 ).
Level of MDA
The change of plasma MDA level, before and after treatment was shown in Figure 2 . After 3 weeks of 
Proportion of subjects with number of acne lesion decreased more than 20% after treatment
Means of MDA level (nmol/mL) in control & treatment groups, pre-and post-treatment treatment, means of MDA level decreased in both groups, however, the difference were not statistically significant.
DISCUSSION
The results of this study showed that the extract of mangosteen rind was effective in reducing number of acne lesions. These results are consistent with in vitro study by Chomnawang, et al 11, 12 demonstrating that EMR has anti-bacterial properties against Propionibacterium acnes and anti-inflammatory activity. 11, 12 Based on the success rate criteria (reduction of number of acne lesion ≥ 20%), the benefit of EMR on non-inflamed lesions (comedos) was higher (63%) than inflamed lesions (papules & Subjects (%) pustules) (35%), although statistically the difference was not significant. In contrast, the response of inflamed-lesion (papules and pustules) was equal between groups receiving EMR and control group.
It seems that antioxidant activities of EMR does not cause anti-inflammatory effect on acne, which is contradictive to the finding from an in vitro study. 12 The reasons behind this phenomenon might be related to the fact that all patient also received topical retinoic acid on the face. As already known, retinoic acid has become a standard treatment for acne and has a stronger antiinflammatory effect. This might mask anti-inflammatory effect of EMR, thus rendering a more inferior effect on the area of chest and back. Pharmacokinetic factors of EMR should also be considered as the determinant of the efficacy of EMR, e.g. dosages, duration, and route of administration.
Capsule containing EMR was given orally and the possibility of enzymatic degradation in alimentary tract and hepatic metabolism could not be excluded. Bioactive xanthone will theoretically circulate systemically throughout the body, but we do not have enough data concerning the fate of this substance in the body.
Other possible explanation, might be due to the short duration of treatment. Three weeks application might be too short for natural source of antioxidant to come out with significant results, compared to synthetic (chemical) antioxidant. The remission of a chronic skin disease such as acne will need, about 1½ up to 2 months. Multifactorial etiology of AV certainly affect the healing process.
A study by Surlinia 8 showed that the level of MDA in the blood of patients with moderate to severe acne vulgaris was significantly higher than that in healthy persons.
Our study recruited participants with mild to moderate AV. The results showed that level of MDA was decreased in both groups, the decrease being slightly but not significantly higher than that in control group. Although the MDA level was approaching the condition of healthy person, but still higher than that in healthy persons, since at the end of the study the subjects were still suffering from AV. Further study is needed to confirm whether the extension of study periode to 6-8 weeks or the increase of the dosage of EMR would normalize the MDA levels.
During this study, no adverse events were found. The dose of EMR used for human in this study was based on bioavailability and toxicity studies in rats. Although liver and kidney function were not explored to confirm any organ damage related to EMR administration, there were no subjects reported any sign and symptom of organ dysfunction during 3 weeks of study and one month afterward.
EMR capsules have been marketed for years and so far we do not find any reports from Indonesian National Agency of Drug and Food Control regarding to its side effects.
From the present study, it is concluded that oral administration of extract of mangosteen rind decreases acne severity in patients with mild and moderate acne vulgaris better than placebo. Antioxidant effect of EMR seem to be unspecific in reducing acne severity which might be related to masking effect of topical retinoic acid.
